Discover 250 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 250
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Spokane WA, Seattle WA, Tacoma WA, Roseville CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Spokane WA, Kalispell MT, Bend OR, Reno NV,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase 3, Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Location: Spokane WA, Billings MT, Palo Alto CA, Cerritos CA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05254743
Phase 3, Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
for
Advanced Metastatic Castration Resistant Prostate Cancer
Location: Spokane WA, Orange CA, Newport Beach CA, Scottsdale AZ,
Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.
Sex: Male
Age: 18+
Code: NCT06609005
Phase 1, Phase 2, Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Spokane WA, Tacoma WA, Fullerton CA, Milwaukee WI,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Location: Spokane WA, Calgary, Denver CO, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04728893
Phase 2, Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Spokane WA, Olympia WA, Portland OR, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
for
NSCLC Stage IV
Location: Spokane WA, North Vancouver, El Segundo CA,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase 3, Recruiting
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
for
Symptomatic Venous Thromboembolism (VTE)
Location: Spokane WA, St. George UT, Englewood CO, Lone Tree CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07213778
Phase 3, Recruiting
A Prospective Total Joint Surgery Registry to Monitor Short- and Long-Term Clinical Outcomes
for
Osteoarthritis
Location: Spokane WA
Sponsor: Spokane Joint Replacement Center
Sex: All
Age: 18+
Code: NCT06687109
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Location: Spokane WA, Seattle WA, Calgary, Vancouver, Fresno CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632444
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease